{"id":"https://openalex.org/W2940792124","doi":"https://doi.org/10.1111/bjd.18047","title":"Persistence of apremilast in moderate\u2010to\u2010severe psoriasis: a real\u2010world analysis of 14 147 apremilast\u2010 and methotrexate\u2010naive patients in the French National Health Insurance database","display_name":"Persistence of apremilast in moderate\u2010to\u2010severe psoriasis: a real\u2010world analysis of 14 147 apremilast\u2010 and methotrexate\u2010naive patients in the French National Health Insurance database","publication_year":2019,"publication_date":"2019-04-25","ids":{"openalex":"https://openalex.org/W2940792124","doi":"https://doi.org/10.1111/bjd.18047","mag":"2940792124","pmid":"https://pubmed.ncbi.nlm.nih.gov/31021438"},"language":"en","primary_location":{"id":"doi:10.1111/bjd.18047","doi":"https://doi.org/10.1111/bjd.18047","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjd.18047","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057668291","display_name":"\u00c9. Sbidian","orcid":"https://orcid.org/0000-0002-1267-5270","observed_orcids":["https://orcid.org/0000-0002-1267-5270"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]},{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]},{"id":"https://openalex.org/I4394709234","display_name":"Epidemiology in dermatology and evaluation of therapeutics","ror":"https://ror.org/011gnc761","country_code":"FR","type":"facility","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4394709234"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"E. Sbidian","raw_affiliation_strings":["AP\u2010HP, H\u00f4pitaux Universitaires Henri Mondor D\u00e9partement de Dermatologie Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France","D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","EA 7379 EpidermE Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France","INSERM Centre d'Investigation Clinique 1430 Cr\u00e9teil F\u201094010 France"],"raw_orcid":"https://orcid.org/0000-0002-1267-5270","affiliations":[{"raw_affiliation_string":"AP\u2010HP, H\u00f4pitaux Universitaires Henri Mondor D\u00e9partement de Dermatologie Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France","institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"EA 7379 EpidermE Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France","institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4394709234"]},{"raw_affiliation_string":"INSERM Centre d'Investigation Clinique 1430 Cr\u00e9teil F\u201094010 France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007909493","display_name":"C\u00e9cile Billionnet","orcid":"https://orcid.org/0000-0002-1905-3183","observed_orcids":["https://orcid.org/0000-0002-1905-3183"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Billionnet","raw_affiliation_strings":["D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080099253","display_name":"Alain Weill","orcid":"https://orcid.org/0000-0001-8687-9092","observed_orcids":["https://orcid.org/0000-0001-8687-9092"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Weill","raw_affiliation_strings":["D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021605461","display_name":"G\u00e9ric Maura","orcid":"https://orcid.org/0000-0001-6597-5122","observed_orcids":["https://orcid.org/0000-0001-6597-5122"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Maura","raw_affiliation_strings":["D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070178712","display_name":"Myriam Mezzarobba","orcid":"https://orcid.org/0000-0001-5281-6704","observed_orcids":["https://orcid.org/0000-0001-5281-6704"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Mezzarobba","raw_affiliation_strings":["D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France","institution_ids":["https://openalex.org/I4210131891"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5057668291"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I197681013","https://openalex.org/I4210130325","https://openalex.org/I4210131891","https://openalex.org/I4394709234"],"apc_list":{"value":2700,"currency":"GBP","value_usd":3800},"apc_paid":null,"fwci":1.357,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.78067042,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"182","issue":"3","first_page":"690","last_page":"697"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apremilast","display_name":"apremilast","score":0.9380000233650208},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.7639999985694885},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.5960000157356262},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5260000228881836},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.7039999961853027},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.5389999747276306},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.859000027179718},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2781427535","wikidata":"https://www.wikidata.org/wiki/Q2858961","display_name":"Apremilast","level":4,"score":0.9885014295578003},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8591116666793823},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7891443967819214},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.6340165734291077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6133482456207275},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4526776969432831},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.37583446502685547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3626860976219177},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.33425065875053406},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009313","descriptor_name":"National Health Programs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjd.18047","doi":"https://doi.org/10.1111/bjd.18047","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjd.18047","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:31021438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31021438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1583293707","https://openalex.org/W1692288477","https://openalex.org/W1721730044","https://openalex.org/W1919283206","https://openalex.org/W1980533403","https://openalex.org/W2131727392","https://openalex.org/W2135210871","https://openalex.org/W2152590022","https://openalex.org/W2163232748","https://openalex.org/W2207240463","https://openalex.org/W2378098209","https://openalex.org/W2460322648","https://openalex.org/W2505357118","https://openalex.org/W2542499183","https://openalex.org/W2606731929","https://openalex.org/W2613498155","https://openalex.org/W2741789802","https://openalex.org/W2772776690","https://openalex.org/W2781078917","https://openalex.org/W2789500270","https://openalex.org/W2791244279","https://openalex.org/W2791275947","https://openalex.org/W2791647987","https://openalex.org/W2794074741","https://openalex.org/W2799813944","https://openalex.org/W2802689151","https://openalex.org/W2804763220","https://openalex.org/W2807816436","https://openalex.org/W2889126816","https://openalex.org/W2908333040","https://openalex.org/W2921726596","https://openalex.org/W4211077900","https://openalex.org/W4253236412","https://openalex.org/W4383998038","https://openalex.org/W6808308688"],"related_works":["https://openalex.org/W4387311088","https://openalex.org/W2945998924","https://openalex.org/W2400057168","https://openalex.org/W6929137841","https://openalex.org/W4225287682","https://openalex.org/W6921049872","https://openalex.org/W4280496157","https://openalex.org/W4284676188","https://openalex.org/W4293229957","https://openalex.org/W4283693517"],"abstract_inverted_index":{"BACKGROUND:":[0],"Real-world":[1],"data":[2,229],"on":[3],"the":[4,17,40,180,198,233,238,253,286,296,337,349,372],"persistence":[5,19,81],"of":[6,20,28,75,80,142,151,171,183,191,236,252,285,300,344,371],"apremilast":[7,21,76,134,174,314,338,392],"vs.":[8],"methotrexate":[9,23,178,350,390],"are":[10],"inconclusive.":[11],"OBJECTIVES:":[12],"To":[13],"assess":[14],"and":[15,22,54,65,101,106,135,156,175,366,369,391],"compare":[16],"long-term":[18,297],"in":[24,39,179,212,232,322,336,348],"a":[25,72,85,168,188,202,213,266,279,323,341,394],"large":[26],"cohort":[27,326,339,351],"patients":[29,35,118,144,155,159,186,195,246,332,347],"with":[30,36,71,88,119,145,274,318,333],"psoriasis.":[31,334],"METHODS:":[32],"All":[33],"adult":[34,117,331],"psoriasis":[37,120,290],"registered":[38],"French":[41],"national":[42],"health":[43],"insurance":[44],"database":[45],"('Syst\u00e8me":[46],"National":[47],"des":[48],"Donn\u00e9es":[49],"de":[50],"Sant\u00e9')":[51],"between":[52,389],"2009":[53],"2017":[55],"were":[56,82,127,149],"eligible":[57],"for":[58,173,177,244,248,313,320],"inclusion.":[59],"The":[60,307],"study":[61,199,305],"population":[62,200],"comprised":[63],"apremilast-":[64],"methotrexate-naive":[66],"patients,":[67,250],"defined":[68],"as":[69,201,362,393],"those":[70],"first":[73,181,234],"prescription":[74],"or":[77,211],"methotrexate.":[78,136],"Levels":[79],"compared":[83,317],"using":[84,352],"Cox":[86],"model":[87],"propensity-score":[89,138,165,353],"matching":[90],"that":[91,231],"included":[92],"potential":[93],"confounders":[94],"(notably":[95],"age,":[96,363],"sex,":[97,364],"psoriatic":[98,367],"arthritis,":[99,368],"comorbidities":[100,365],"previous":[102,254,373],"exposure":[103],"to":[104,129,132],"topical":[105],"systemic":[107,396],"treatments).":[108],"RESULTS:":[109],"In":[110,377],"this":[111,262,304],"nationwide":[112,324],"population-based":[113,325],"cohort,":[114],"14":[115,328],"147":[116,329],"(mean":[121],"age":[122],"52\u00b73":[123],"years,":[124],"55\u00b72%":[125],"male)":[126],"found":[128],"be":[130],"naive":[131],"both":[133],"After":[137],"matching,":[139,354],"two":[140],"subgroups":[141],"4805":[143],"similar":[146],"baseline":[147],"characteristics":[148],"included,":[150],"whom":[152],"3207":[153],"apremilast-treated":[154,245],"2736":[157],"methotrexate-treated":[158,194,249],"discontinued":[160],"their":[161],"treatment.":[162,184],"Kaplan-Meier":[163],"survival":[164],"analyses":[166],"revealed":[167],"discontinuation":[169,192,239,308,345],"rate":[170,240,309],"69%":[172],"59%":[176],"year":[182,235,312],"Apremilast-treated":[185],"had":[187,340],"higher":[189,243,342],"risk":[190,343,359],"than":[193,247,346],"when":[196,387],"considering":[197],"whole":[203],"(hazard":[204,216],"ratio":[205,217],"1\u00b728,":[206],"95%":[207,219],"confidence":[208,220],"interval":[209,221],"1\u00b723-1\u00b734)":[210],"propensity-score-matched":[214],"analysis":[215],"1\u00b734,":[218],"1\u00b727-1\u00b741;":[222],"P":[223],"<":[224],"0\u00b7001).":[225],"CONCLUSIONS:":[226],"Our":[227],"real-world":[228],"suggest":[230],"treatment,":[237],"was":[241,315],"significantly":[242],"regardless":[251,370],"therapeutic":[255,374],"lines":[256,375],"received.":[257,376],"What's":[258],"already":[259],"known":[260,294],"about":[261,295],"topic?":[263],"Psoriasis":[264],"is":[265,283,293],"common":[267],"chronic,":[268],"relapse-remitting,":[269],"inflammatory":[270],"skin":[271],"disease":[272],"associated":[273],"severe":[275],"psychosocial":[276],"impact.":[277],"Apremilast,":[278],"phosphodiesterase":[280],"4":[281],"inhibitor,":[282],"one":[284],"most":[287],"recently":[288],"commercialized":[289],"drugs.":[291],"Little":[292],"clinical":[298],"effectiveness":[299],"apremilast.":[301],"What":[302],"does":[303],"add?":[306],"at":[310],"1":[311],"69%,":[316],"58%":[319],"methotrexate,":[321],"including":[327,355],"nonselected":[330],"Patients":[335],"potentially":[356],"relevant":[357],"individual":[358],"factors":[360],"such":[361],"daily":[378],"practice,":[379],"physicians":[380],"should":[381],"take":[382],"these":[383],"results":[384],"into":[385],"account":[386],"choosing":[388],"first-line":[395],"therapy.":[397]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-05-03T00:00:00"}